FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, particularly to treating bronchopulmonary dysplasia. A method involves administering an effective amount of citrulline into the patient. What is also presented is a pharmaceutical composition applicable for intravenous administration, containing a pharmaceutically acceptable carrier and an amount of citrulline effective for increasing blood plasma citrulline. The level is measured by comparing plasma citrulline in the patient under treatment to that in the patient having no bronchopulmonary dysplasia. The given composition is presented for producing a preparation for injections.
EFFECT: inventions provide the effective treatment of bronchopulmonary dysplasia by the polycomponent effect of citrulline on the disease process.
11 cl, 8 dwg, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONSEQUENCES OF LUNG DAMAGE INDUCED BY ARTIFICIAL BLOOD CIRCULATION | 2017 |
|
RU2762593C2 |
| INTRAVENOUS INTRODUCTION OF CITRULLINE DURING SURGICAL INTERVENTION | 2016 |
|
RU2733738C2 |
| METHODS AND FORMULATIONS FOR TREATING SUBARACHNOIDAL HAEMORRHAGE OF CORONARY AND ARTERIAL ANEURISM | 2009 |
|
RU2528097C2 |
| REDUCTION OF ARGINASE LEVELS/ACTIVITY | 2007 |
|
RU2469742C2 |
| COMPOSITION POSSESSING ENDOTHELIAL PROTECTIVE, VASODILATING AND ANGIOPROTECTIVE EFFECT | 2011 |
|
RU2464019C1 |
| METHODS OF TREATING WITH USING CITRULLINE | 2007 |
|
RU2444355C2 |
| USE OF OXATHRIAZOLO-5-OLATE FOR TREATING SEXUAL DISORDERS | 2014 |
|
RU2600845C2 |
| METHOD FOR CORRECTING ENDOTHELIAL REGULATION OF PATIENT VASCULAR TONUS | 1999 |
|
RU2170102C1 |
| METHOD OF TREATMENT OF ISOLATED SYSTOLIC ARTERIAL HYPERTENSION OF 1 DEGREE IN PATIENTS IN EARLY PERIOD OF OLD AND SENILE AGE | 2019 |
|
RU2726071C1 |
| AGENT FOR DRUG-INDUCED CORRECTION OF NITROXYDERGIC DISORDERS | 2012 |
|
RU2505297C1 |
